ArticleTherapeutic advances in rare disease

Progress and perspectives in primary mitochondrial myopathy: Highlights from the 2025 mitochondrial medicine masterclass with a focus on TK2 deficiency.

Austin Larson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.